The NWBO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NWBO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NWBO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NWBO Detailed Price Forecast - CNN Money||View NWBO Detailed Summary - Google Finance|
|View NWBO Detailed Summary - Yahoo! Finance||View NWBO Stock Research & Analysis - Zacks.com|
|View NWBO Trends & Analysis - Trade-Ideas||View NWBO Major Holders - Barrons|
|View NWBO Call Transcripts - NASDAQ||View NWBO Breaking News & Analysis - Seeking Alpha|
|View NWBO Annual Report - CompanySpotlight.com||View NWBO OTC Short Report - OTCShortReport.com|
|View NWBO Fundamentals - TradeKing||View NWBO SEC Filings - Bar Chart|
|View Historical Prices for NWBO - The WSJ||View Performance/Total Return for NWBO - Morningstar|
|View the Analyst Estimates for NWBO - MarketWatch||View the Earnings History for NWBO - CNBC|
|View the NWBO Earnings - StockMarketWatch||View NWBO Buy or Sell Recommendations - MacroAxis|
|View the NWBO Bullish Patterns - American Bulls||View NWBO Short Pain Metrics - ShortPainBot.com|
|View NWBO Stock Mentions - StockTwits||View NWBO Stock Mentions - PennyStockTweets|
|View NWBO Stock Mentions - Twitter||View NWBO Investment Forum News - Investor Hub|
|View NWBO Stock Mentions - Yahoo! Message Board||View NWBO Stock Mentions - Seeking Alpha|
|View Insider Transactions for NWBO - SECform4.com||View Insider Transactions for NWBO - Insider Cow|
|View NWBO Major Holdings Summary - CNBC||View Insider Disclosure for NWBO - OTC Markets|
|View Insider Transactions for NWBO - Yahoo! Finance||View Institutional Holdings for NWBO - NASDAQ|
|View NWBO Stock Insight & Charts - FinViz.com||View NWBO Investment Charts - StockCharts.com|
|View NWBO Stock Overview & Charts - BarChart||View NWBO User Generated Charts - Trading View|
NW Bio Congratulates Cognate BioServices On Its Management Buyout
Posted on Tuesday February 20, 2018
BETHESDA, Md., Feb. 20, 2018 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, congratulated Cognate BioServices, the contract manufacturer of NWBio's DCVax® products, on the Management Buyout of Cognate supported by global institutional investors, which Cognate announced today. Following this transaction, neither Linda Powers nor any Toucan Capital related entities have any ownership interest in Cognate or any role on Cognate's Board. More information can be found in a Cognate press release at https://www.businesswire.com/news/home/20180220006077/en.
NW Bio Announces Regulation D Offering for Accredited Investors
Posted on Tuesday December 19, 2017
BETHESDA, Md., Dec. 19, 2017 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) -- (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it is commencing a general solicitation Regulation D offering to accredited investors. The Offering will remain open for execution of subscription agreements until 5:30 pm EST on Wednesday, December 27, 2017, and the closing is expected to take place on Friday, December 29, 2017.
NW Bio Announces Completion of $12 Million Financing
Posted on Monday December 04, 2017
BETHESDA, Md., Dec. 4, 2017 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) (NWBio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has completed a $12 million financing to fund operations. The majority of the financing is being provided by new investors. The financing is in the form of Series A Convertible Preferred Stock and Warrants. The Preferred Stock will be convertible into common stock, but only when common stock is available or after 6 months following issuance. The Warrants will be exercisable for common stock, but only when common stock is available. The shares are registered, but are subject to restrictions under which they may not be conveyed or traded until a shareholder vote takes place, pursuant to which the number of authorized shares is increased. The shares are also subject to a voting agreement, under which the investors have agreed to vote in support of such increase in authorized shares.
NW Bio Reports Favorable Results and Progress In Resolving Lawsuits
Posted on Monday October 30, 2017
BETHESDA, Md., Oct. 30, 2017 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for operable and inoperable solid tumor cancers, is pleased to report meaningful progress in resolving four lawsuits that were brought against it as reported in the Company's periodic filings. Every claim was dismissed. On April 12, 2017, the lead plaintiffs submitted a letter to the court advising it that they were not going to file an amended complaint, and the deadline for filing an appeal has now expired. This action is over.